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Gene expression vectors are the starting point for the manufacturing of recombinant protein therapeutics. Key 
performance criteria for an industrial vector system are speed, ease of assembly, and flexibility. As recombinant 
protein therapeutics become ever more complex and encompass increasingly diverse formats with multiple 
protein chains, it is essential for the gene expression technology platforms to evolve in-sync to facilitate cell line 
construction and manufacturing. Over the last couple of years, we have explored updates to the Lonza GS gene 
expression vector system, primarily to speed vector construction timelines but also to increase flexibility for 
complex proteins. This work has encompassed different vector assembly methodologies, as well as traditional 
cut-and-paste protocols. In this poster we present the results of this research and illustrate how relatively small 
changes to existing vector designs can have a big impact on performance. We show how different vector 
assembly methods can be used to provide solutions for specific protein formats and end user objectives. 
Furthermore, we show how strict vector design constraints can affect the performance of DNA cloning methods, 
and suggest how vector components can be updated to achieve further optimisations. This work contains 
lessons for the continuing evolution of DNA vectors in the face of the continuing revolution in recombinant 
therapeutic protein design.  
 
 
 
 
